LRP1 and glioblastoma: To target GOLPH3 as a therapeutic target for glioblastoma treatment, Yuan et al. used angiotensin-2 (LRP-1-specific ligand)-functionalized cationic liposomes for the encapsulation and targeted delivery of GOLPH3-siRNA [122].